238 related articles for article (PubMed ID: 21527666)
1. LIF is a contraction-induced myokine stimulating human myocyte proliferation.
Broholm C; Laye MJ; Brandt C; Vadalasetty R; Pilegaard H; Pedersen BK; Scheele C
J Appl Physiol (1985); 2011 Jul; 111(1):251-9. PubMed ID: 21527666
[TBL] [Abstract][Full Text] [Related]
2. Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes.
Broholm C; Brandt C; Schultz NS; Nielsen AR; Pedersen BK; Scheele C
Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E283-92. PubMed ID: 22649064
[TBL] [Abstract][Full Text] [Related]
3. Leukaemia inhibitory factor--an exercise-induced myokine.
Broholm C; Pedersen BK
Exerc Immunol Rev; 2010; 16():77-85. PubMed ID: 20839492
[TBL] [Abstract][Full Text] [Related]
4. Resistance exercise induced mTORC1 signaling is not impaired by subsequent endurance exercise in human skeletal muscle.
Apró W; Wang L; Pontén M; Blomstrand E; Sahlin K
Am J Physiol Endocrinol Metab; 2013 Jul; 305(1):E22-32. PubMed ID: 23632629
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression.
Kamohara H; Ogawa M; Ishiko T; Sakamoto K; Baba H
Int J Oncol; 2007 Apr; 30(4):977-83. PubMed ID: 17332938
[TBL] [Abstract][Full Text] [Related]
6. α₁-Adrenoceptor stimulation enhances leukemia inhibitory factor-induced proliferation of mouse-induced pluripotent stem cells.
Ishizuka T; Watanabe Y
Eur J Pharmacol; 2011 Oct; 668(1-2):42-56. PubMed ID: 21745467
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
8. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic resistance training downregulates select LINE-1 retrotransposon activity markers in human skeletal muscle.
Romero MA; Mobley CB; Mumford PW; Roberson PA; Haun CT; Kephart WC; Healy JC; Beck DT; Young KC; Martin JS; Lockwood CM; Roberts MD
Am J Physiol Cell Physiol; 2018 Mar; 314(3):C379-C388. PubMed ID: 29351416
[TBL] [Abstract][Full Text] [Related]
10. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
11. Acute myotube protein synthesis regulation by IL-6-related cytokines.
Gao S; Durstine JL; Koh HJ; Carver WE; Frizzell N; Carson JA
Am J Physiol Cell Physiol; 2017 Nov; 313(5):C487-C500. PubMed ID: 28768641
[TBL] [Abstract][Full Text] [Related]
12. Examination of pathways involved in leukemia inhibitory factor (LIF)-induced cell growth arrest using label-free proteomics approach.
Ali SA; Kaur G; Kaushik JK; Malakar D; Mohanty AK; Kumar S
J Proteomics; 2017 Sep; 168():37-52. PubMed ID: 28755912
[TBL] [Abstract][Full Text] [Related]
13. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
14. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
Morton SD; Cadamuro M; Brivio S; Vismara M; Stecca T; Massani M; Bassi N; Furlanetto A; Joplin RE; Floreani A; Fabris L; Strazzabosco M
Oncotarget; 2015 Sep; 6(28):26052-64. PubMed ID: 26296968
[TBL] [Abstract][Full Text] [Related]
15. Electrical pulse stimulation: an in vitro exercise model for the induction of human skeletal muscle cell hypertrophy. A proof-of-concept study.
Tarum J; Folkesson M; Atherton PJ; Kadi F
Exp Physiol; 2017 Nov; 102(11):1405-1413. PubMed ID: 28861930
[TBL] [Abstract][Full Text] [Related]
16. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
[TBL] [Abstract][Full Text] [Related]
17. Myokine Expression in Muscle and Myotubes in Response to Exercise Stimulation.
Covington JD; Tam CS; Bajpeyi S; Galgani JE; Noland RC; Smith SR; Redman LM; Ravussin E
Med Sci Sports Exerc; 2016 Mar; 48(3):384-90. PubMed ID: 26460627
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract][Full Text] [Related]
19. Cytokine response of primary human myotubes in an in vitro exercise model.
Scheler M; Irmler M; Lehr S; Hartwig S; Staiger H; Al-Hasani H; Beckers J; de Angelis MH; Häring HU; Weigert C
Am J Physiol Cell Physiol; 2013 Oct; 305(8):C877-86. PubMed ID: 23926130
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
